Education

Quality Improvement Program Webinar—Breast and Ovarian Cancer Biomarker Testing

Quality Improvement Program Webinar—NSCLC Biomarker Testing

Lung Cancer Patient with 3 EGFR Mutations

Ovarian Cancer Patient with Somatic BRCA1 Reversion Mutation

Ovarian and Lung Cancer Patients with BRCA Reversion and Three EGFR Mutations

NCCN updates: Stage IB – IIA NSCLC with EGFR Alteration Patients

Stage IA3 Patient with EGFR Exon 19 Deletion Alteration and High-risk DetermaRx Result

NSCLC Patient and Adjuvant Chemotherapy

Patient with Possible Synchronous Early-stage NSCLC and Different DetermaRx Results

Patient with NSCLC Who Recurred within a Year

Patient with Stage IB NSCLC, an Oncocyte DetermaRx High-Risk Result and an EGFR Exon 19 Deletion

Stratification of Early-Stage, Non-squamous NSCLC Patients Likely to Benefit from Early, Post-operative Chemotherapy

MTC: Patient with Stomach Cancer and KIT exon 11 and ATM Mutations

Patient with Prostate Cancer and CDK12 and TP53 Mutations

MTB Discussion for Patients with KIT and CDK12 Mutations

Overview of New CoC Standards